Vaxcyte, Inc. (PCVX) Net income 2018–2025
Vaxcyte, Inc. (PCVX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$766.6MFY2025 · since FY2018: -$29.5M → -$766.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$766.6M | -65.2% |
| FY2024 | -$463.9M | -15.3% |
| FY2023 | -$402.3M | -80.0% |
| FY2022 | -$223.5M | -123.3% |
| FY2021 | -$100.1M | -12.2% |
| FY2020 | -$89.2M | -77.5% |
| FY2019 | -$50.3M | -70.5% |
| FY2018 | -$29.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PCVX financial trends
PCVX RevenuePCVX Net marginPCVX Gross profitPCVX Gross marginPCVX Operating incomePCVX Operating marginPCVX Operating cash flowPCVX Free cash flowPCVX Capital expendituresPCVX Return on equityPCVX Stock buybacksPCVX Dividends paidPCVX Total assetsPCVX Total liabilitiesPCVX Shareholders’ equityPCVX overview →